1-4 of 4
Christine Chen, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Trial of Myeloma Induction Therapy with Cyclophosphamide, Bortezomib, and Dexamethasone (Cybor-D): Improved Response over Historical Lenalidomide-Dexamethasone Controls.

Craig B. Reeder, MD, Donna E. Reece, M.D., Rafael Fonseca, M.D., P. Leif Bergsagel, M.D., Joseph Hentz, MSc., Nicholas A. Pirooz, BSc., Jacy E. Boesiger, RN., Jesus G. Pisa, M.D., Vishal Kukreti, M.D., Christine Chen, M.D., Suzanne Trudel, M.D., Joseph R. Mikhael, M.D., Martha Lacy, M.D., S. Vincent Rajkumar, M.D., A. Keith Stewart, M.D.
Journal: Blood
Blood (2007) 110 (11): 3601.
https://doi.org/10.1182/blood.V110.11.3601.3601
Published: 2007
Journal Articles

Predictors of Mortality in Patients Undergoing Autologous Stem Cell Transplant (ASCT) Admitted to the Intensive Care Unit: An Institutional Review of 1013 Transplant Patients over Five Years.

Martina A. Trinkaus, MD, Stephen E. Lapinsky, M.D., David C. Hallett, M.Sc, Norman Franke, M.D., Andrew Winter, B.ScN, Michael Crump, M.D., Donna E. Reece, M.D., Christine Chen, M.D., Suzanne Trudel, M.D., Ian Quirt, M.D., Armand Keating, M.D., Joseph R. Mikhael, M.D.
Journal: Blood
Blood (2007) 110 (11): 2876.
https://doi.org/10.1182/blood.V110.11.2876.2876
Published: 2007
Journal Articles

Effect of the Percent Decrease in Monoclonal Protein with Induction Therapy on the Outcome after Autologous Stem Cell Transplantation in Patients with IgG and IgA Multiple Myeloma.

Donna E. Reece, MD, Young Trieu, M.S., Alida Pokoradi, B.S., Wei Xu, Ph.D., Sharon Fung, M.S., Christine Chen, M.D., Vishal Kukreti, M.D., Joseph Mikhael, M.D., Suzanne Trudel, M.D., A. Keith Stewart, M.D.
Journal: Blood
Blood (2007) 110 (11): 950.
https://doi.org/10.1182/blood.V110.11.950.950
Published: 2007
Journal Articles

Lenalidomide Plus High-Dose Dexamethasone Provides Improved Overall Survival Compared to High-Dose Dexamethasone Alone for Relapsed or Refractory Multiple Myeloma (MM): Results of 2 Phase III Studies (MM-009, MM-010) and Subgroup Analysis of Patients with Impaired Renal Function.

Donna Weber, MD, Michael Wang, M.D., Christine Chen, M.D., Andrew Belch, M.D., Edward A. Stadtmauer, M.D., Ruben Niesvisky, M.D., Zhinuan Yu, Marta Olesnyckyj, Jerome Zeldis, M.D., Robert D. Knight, M.D., Meletios Dimopoulos, M.D.
Journal: Blood
Blood (2006) 108 (11): 3547.
https://doi.org/10.1182/blood.V108.11.3547.3547
Published: 2006